期刊文献+

两种筛查宫颈肿瘤方法的比较:ELISA检测宫颈脱落细胞p16^(INK4a)蛋白与FQ-PCR检测8种共用型HPV DNA 被引量:3

Comparison of two methods for screening of cervical carcinoma:detecting p16^(INK4a) in cervical exfoliative cells with ELISA and detecting HR-HPV DNA with FQ-PCR
下载PDF
导出
摘要 目的:探讨用ELISA方法检测p16INK4a蛋白在宫颈脱落细胞的表达,筛查宫颈癌。方法:选取宫颈组织活检标本1523例,活检前用棉拭子从标本中获取宫颈脱落细胞。用荧光定量聚合酶链反应(FQ-PCR)法检测宫颈活检组织中8种亚型HR-HPV DNA,用ELISA方法检测宫颈脱落细胞中p16INK4a蛋白的表达。结果:HR-HPV DNA阳性率在CINⅠ、Ⅱ、Ⅲ及宫颈癌中,分别为91.9%,92.8%,94.4%,91.7%,其阳性率与宫颈病变严重程度无显著相关(P=0.893);非肿瘤性病变人群HR-HPV DNA阳性率16.3%;FQ-PCR方法的特异性83.7%。ELISA方法检测宫颈脱落细胞中p16INK4a表达用于筛查宫颈癌及CIN的总体敏感性和特异性分别为87.4%和92.4%,且宫颈病变级别越高,p16INK4a表达越强(r=0.773,P<0.001)。结论:FQ-PCR检测HR-HPV DNA用于筛查宫颈癌及CIN,敏感度高但特异性较低;ELISA检测p16INK4a蛋白表达具有较高的灵敏度和特异性,有望成为宫颈癌新的筛查方法在临床推广使用。 Objection:To explore cervical carcinoma with ELISA to detecting p16^INK4a expression in cervical exfoliative cells. Methods :1523 specimens who under biopsy were selected. Before biopsy,a cotton swab was used to turning twice at the ectocervical and endocervical parts of the cervix to gather exfoliative cells. Fluorescent quantitated polymerase chain reaction (FQ-PCR) was used to detect HR-HPV( HPV-16,18,31,33,45,52,56,58) DNA of biopsy; ELISA was employed to measure p16^INK4a protein in exfoliatiave cells. Results:The positive rate of HR-HPV in cervical intraepithelial neoplasia(CIN) Ⅰ , Ⅱ,Ⅲand carcinoma was 91.9% , 92.8% ,94.4% ,91.7% ,respectively. There was no significant relationship between infection rate of HR-HPV and severity of cervical lesion. The specificity of FQ-PCR for screening of cervical cancer and CIN was 83.7%. The sensitivity and specificity of ELISA for screening out significant cervical disease was 87.4% and 92.4% respectively. p16^INK4a expression was correlated with the severity of cervical damage ( r = 0. 773, P〈0. 001 ). Conclusions : Detecting HRHPV is sensitive for screening out significant cervix lesion but also with low specificity of 83. 7%. Measuring p16^INK4a witll ELISA for screening out significant cervix lesion is sensitive andspecify. It is prospective to be applied as a new screening tool for cervical carcinoma.
出处 《现代妇产科进展》 CSCD 北大核心 2010年第1期37-40,共4页 Progress in Obstetrics and Gynecology
关键词 宫颈肿瘤 宫颈上皮内瘤变 P16^INK4A 酶联免疫吸附测定 荧光定量聚合酶链反应 高危型人乳头瘤病毒 Cervical neoplasms Cervical intraepithelial neoplasia p16^INK4a Enzymelinked immunosorbent assay Fluorescent quantitated polymerase chain reaction High-risk human papilloma virus
  • 相关文献

参考文献19

  • 1O'Connor DM. The use of p16 as a marker for cervical cancer precursor lesions : a review [ J ]. J Low Genit Tract Dis ,2007,11:67-68.
  • 2Kim YT, Zhao M. Aberrant cell cycle regulation in cervical carcinoma[ J ]. Yonsei Med J ,2005,46:597-613.
  • 3Tringler B, Gup CJ, Singh M, et al. Evaluation of p16^INK4a and pRb expression in cervical squamous and glandular neoplasia[ J ]. Hum Pathol, 2004,35:689-696.
  • 4Marjoniemi VM. Immunohistochemistry in gynaecological pathology : a review [ J ]. Pathology ,2004,36 : 109-119.
  • 5邹先进,蔡兰,刘颖,王梅,谢军花.子宫颈癌前病变与子宫颈癌组织中p16^(INK4A)蛋白检测及其与人乳头状瘤病毒感染的关系[J].中华妇产科杂志,2004,39(9):625-626. 被引量:25
  • 6Ding L, Zou X J, Ao JE, et al. ELISA test to detect CDKN2A(p16^INK4a) expression in exfoliative cells: a new screening tool for cervical cancer [ J ]. Mol Diag Ther, 2008,12 : 395-400.
  • 7Franco EL. Chapter 13 :primary screening of cervical cancer with human papillomavirus tests [ J ]. J Nail Cancer Inst Monogr,2003,31 : 89-96.
  • 8Lorincz AT, Richart RM. Human papillomavirus DNA testing as an adjunct to cytology in cervical screening programs [ J ]. Arch Pathol Lab Med, 2003,127:959-968.
  • 9Castle PE,Wacholder S,Sherman ME,et al. Absolute risk of a subsequent abnormal pap among oncogenic human papillomavirus DNA-positive, cytologically negative women [ J ]. Cancer, 2002,95 : 2145-2151.
  • 10von Knebel Doeberitz M. New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections [ J ]. Eur J Cancer, 2002,38 : 2229-2242.

二级参考文献5

  • 1Negri G,Egarter-Vigl E,Kasal A,et al.p16 INK4A is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors: an immunohistochemical study with immunocytochemical correlations.Am J Surg Pathol,2003 ,27:187-193.
  • 2Keating JT,Ince T,Crum CP.Surrogate biomarkers of HPV infection in cervical neoplasia screening and diagnosis.Adv Anat Pathol 2001,8:83-92.
  • 3Keating JT,Cviko A,Riethdorf S,et al.Ki-67,cyclin E,and p16 INK4A are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia.Am J Surg Pathol,2001 ,25:884-891.
  • 4Murphy N,Ring M,Killalea AG,et al.p16 INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears.J Clin Pathol,2003 ,56:56-63.
  • 5Bibbo M,Klump WJ,DeCecco J,et al.Procedure for immunocytochemical detection of p16 INK4A antigen in thin-layer,liquid-based specimens.Acta Cytol,2002 ,46:25-29.

共引文献24

同被引文献18

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部